Table of Contents
ISRN AIDS
Volume 2012, Article ID 565463, 7 pages
http://dx.doi.org/10.5402/2012/565463
Clinical Study

Clinicopathological Proficiency in the Diagnosis of Kaposi's Sarcoma

National Health Laboratory Service, Polokwane/Mankweng Hospital Complex and University of Limpopo, Limpopo Province, 0700 Polokwane, South Africa

Received 21 March 2012; Accepted 9 April 2012

Academic Editors: K. Gee, L. Gray, and C. Petrovas

Copyright © 2012 Louis-Jacques van Bogaert. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Aldenhoven, N. P. Barlo, and C. J. G. Sanders, “Therapeutic strategies for epidemic Kaposi's sarcoma,” International Journal of STD & AIDS, vol. 17, no. 9, pp. 571–578, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. S. M. Mbulaiteye, E. T. Katabira, H. Wabinga et al., “Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study,” International Journal of Cancer, vol. 118, no. 4, pp. 985–990, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. D. M. Parkin, “The global health burden of infection-associated cancers in the year 2002,” International Journal of Cancer, vol. 118, no. 12, pp. 3030–3044, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Chokunonga, L. M. Levy, M. T. Bassett, B. G. Mauchaza, D. B. Thomas, and D. M. Parkin, “Cancer incidence in the African population of Harare, Zimbabwe: second results from the cancer registry 1993–1995,” International Journal of Cancer, vol. 85, no. 1, pp. 54–59, 2000. View at Publisher · View at Google Scholar
  5. G. Wamburu, E. J. Masenga, E. Z. Moshi, P. Schmid-Grendelmeier, W. Kempf, and C. E. Orfanos, “HIV-associated and non-HIV associated types of Kaposi's sarcoma in an African population in Tanzania. Status of immune suppression and HHV-8 seroprevalence,” European Journal of Dermatology, vol. 16, no. 6, pp. 677–682, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. J. L. Urquhart, A. Uzieblo, and S. Kohler, “Detection of HHV-8 in pyogenic granuloma-like kaposi sarcoma,” The American Journal of Dermatopathology, vol. 28, no. 4, pp. 317–321, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. “Mid-year population estimates,” 2010, http://www.statssa.gov.za/.
  8. National Department of Health, National HIV Counseling and Testing Policy Guidelines, Department of Health, Pretoria, South Africa, 2010.
  9. Y. Chang, E. Cesarman, M. S. Pessin et al., “Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma,” Science, vol. 266, no. 5192, pp. 1865–1869, 1994. View at Google Scholar · View at Scopus
  10. N. Dupin, C. Fisher, P. Kellam et al., “Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 8, pp. 4546–4551, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. E. J. Schwartz, R. F. Dorfman, and S. Kohler, “Human herpesvirus-8 latent nuclear antigen-1 expression in endemic kaposi sarcoma: an immunohistochemical study of 16 cases,” The American Journal of Surgical Pathology, vol. 27, no. 12, pp. 1546–1550, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. R. M. Patel, J. R. Goldblum, and E. D. Hsi, “Immunohistochemical detection of human herpes virus-8 latent nuclear antigen-1 is useful in the diagnosis of Kaposi sarcoma,” Modern Pathology, vol. 17, no. 4, pp. 456–460, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. W. Cheuk, K. O. Y. Wong, C. S. C. Wong, J. E. Dinkel, D. Ben-Dor, and J. K. C. Chan, “Immunostaining for human herpesvirus 8 latent nuclear antigen-1 helps distinguish kaposi sarcoma from its mimickers,” American Journal of Clinical Pathology, vol. 121, no. 3, pp. 335–342, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. J. A. Ramirez, W. B. Laskin, and J. Guitart, “Lymphangioma-like Kaposi sarcoma,” Journal of Cutaneous Pathology, vol. 32, no. 4, pp. 286–292, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Pyakurel, F. Pak, A. R. Mwakigonja, E. Kaaya, T. Heiden, and P. Biberfeld, “Lymphatic and vascular origin of Kaposi's sarcoma spindle cells during tumor development,” International Journal of Cancer, vol. 119, no. 6, pp. 1262–1267, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. W. Grayson and L. Pantanowitz, “Histological variants of cutaneous Kaposi sarcoma,” Diagnostic Pathology, vol. 3, no. 1, pp. 31–48, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. P. J. O'Donnell, L. Pantanowitz, and W. Grayson, “Unique histologic variants of cutaneous Kaposi sarcoma,” The American Journal of Dermatopathology, vol. 32, no. 3, pp. 244–250, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Russell Jones, G. Orchard, B. Zelger, and E. Wilson Jones, “Immunostaining for CD31 and CD34 in Kaposi sarcoma,” Journal of Clinical Pathology, vol. 48, no. 11, pp. 1011–1016, 1995. View at Google Scholar · View at Scopus
  19. K. M. Chu, G. Mahlangeni, S. Swannet, N. P. Ford, A. Boulle, and G. Van Cutsem, “AIDS-associated Kaposi's sarcoma is linked to advanced disease and high mortality in a primary care HIV programme in South Africa,” Journal of the International AIDS Society, vol. 13, no. 1, pp. 23–27, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Kumarasamy, K. K. Venkatesh, B. Devaleenol, S. Poongulali, and N. Ahilasamy, “Regression of Kaposi's sarcoma lesions following highly active antiretroviral therapy in an HIV-infected patient,” International Journal of STD & AIDS, vol. 19, no. 11, pp. 786–788, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. P. A. Agaba, H. M. Sule, R. O. Ojoh et al., “Presentation and survival of patients with AIDS-related Kaposi's sarcoma in Jos, Nigeria,” International Journal of STD & AIDS, vol. 20, no. 6, pp. 410–413, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Calonje, “Vascular tumors: tumors and tumor-like conditions of blood vessels and lymphatics,” in Lever’s Histopathology of the Skin, D. Elder, Ed., pp. 1007–1056, Wolters/Kluwer/Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 10th edition, 2009. View at Google Scholar
  23. T. Mentzel and H. Kutzner, “Haemorrhagic dermatomyofibroma (plaque-like dermal fibromatosis): clinicopathological and immunohistochemical analysis of three cases resembling plaque-stage Kaposi's sarcoma,” Histopathology, vol. 42, no. 6, pp. 594–598, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. D. A. Wada, S. L. Perkins, S. Tripp, C. M. Coffin, and S. R. Florell, “Human herpesvirus 8 and iron staining are useful in differentiating Kaposi sarcoma from interstitial granuloma annulare,” American Journal of Clinical Pathology, vol. 127, no. 2, pp. 263–270, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. O. W. Mwanda, P. Fu, R. Collea, C. Whalen, and S. C. Remick, “Kaposi's sarcoma in patients with and without human immunodeficiency virus infection, in a tertiary referral centre in Kenya,” Annals of Tropical Medicine and Parasitology, vol. 99, no. 1, pp. 81–91, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. W. Phipps, F. Ssewankambo, H. Nguyen et al., “Gender differences in clinical presentation and outcomes of epidemic kaposi sarcoma in Uganda,” PLoS ONE, vol. 5, no. 11, Article ID e13936, 2010. View at Publisher · View at Google Scholar · View at Scopus